摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl N-[2-[tert-butoxycarbonyl-[2-[tert-butoxycarbonyl-[2-[(2,2,2-trifluoroacetyl)amino]ethyl]amino]ethyl]amino]ethyl]-N-[2-[(2,2,2-trifluoroacetyl)amino]ethyl]carbamate | 556082-15-6

中文名称
——
中文别名
——
英文名称
tert-butyl N-[2-[tert-butoxycarbonyl-[2-[tert-butoxycarbonyl-[2-[(2,2,2-trifluoroacetyl)amino]ethyl]amino]ethyl]amino]ethyl]-N-[2-[(2,2,2-trifluoroacetyl)amino]ethyl]carbamate
英文别名
di-tert-butyl (((tert-butoxycarbonyl)azanediyl)bis(ethane-2,1-diyl))bis((2-(2,2,2-trifluoroacetamido)ethyl)carbamate);N,N'-([(tert-butoxycarbonyl)imino]bis{ethylene[(tert-butoxycarbonyl)imino]ethylene})bis(trifluoroacetamide);1,13-di(trifluoroacetyl)-4,7,10-tris(Boc)tetraethylenepentamine;tert-butyl N,N-bis[2-[(2-methylpropan-2-yl)oxycarbonyl-[2-[(2,2,2-trifluoroacetyl)amino]ethyl]amino]ethyl]carbamate
tert-butyl N-[2-[tert-butoxycarbonyl-[2-[tert-butoxycarbonyl-[2-[(2,2,2-trifluoroacetyl)amino]ethyl]amino]ethyl]amino]ethyl]-N-[2-[(2,2,2-trifluoroacetyl)amino]ethyl]carbamate化学式
CAS
556082-15-6
化学式
C27H45F6N5O8
mdl
——
分子量
681.673
InChiKey
OWYRKMAIWHTSFC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    46
  • 可旋转键数:
    18
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.81
  • 拓扑面积:
    147
  • 氢给体数:
    2
  • 氢受体数:
    14

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    tert-butyl N-[2-[tert-butoxycarbonyl-[2-[tert-butoxycarbonyl-[2-[(2,2,2-trifluoroacetyl)amino]ethyl]amino]ethyl]amino]ethyl]-N-[2-[(2,2,2-trifluoroacetyl)amino]ethyl]carbamateN,N-二异丙基乙胺 、 sodium hydroxide 作用下, 以 四氢呋喃乙醇乙腈 为溶剂, 反应 21.75h, 生成 5-[2-[tert-butoxycarbonyl-[2-[tert-butoxycarbonyl-[2-[tert-butoxycarbonyl-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl]amino]ethyl]amino]ethyl]amino]ethylamino]-5-oxopentanoic acid
    参考文献:
    名称:
    用于固相合成确定的聚酰胺酰胺的新型Fmoc-聚氨基酸
    摘要:
    开发了一种通用的固相方法,用于确定序列的聚酰胺胺。四种不同的Fmoc-聚氨基酸结构单元是通过对对称的低聚乙炔亚胺前体进行选择性保护,然后使用环酐引入羧酸的处理方法以及随后的Fmoc保护来合成的。新型Fmoc-聚氨基酸用于构建聚酰胺酰胺,证明与标准Fmoc反应条件完全相容。结构单元的直接合成和固相偶联反应的高效率使所定义的聚阳离子的多功能合成成为可能。
    DOI:
    10.1021/ol200381z
  • 作为产物:
    参考文献:
    名称:
    Trehalose Click Polymers Inhibit Nanoparticle Aggregation and Promote pDNA Delivery in Serum
    摘要:
    Herein, three new glycopolymers have been synthesized via "click polymerization" to promote nucleic acid delivery in the presence of biological media containing serum. These structures were designed to contain a trehalose moiety to promote biocompatibility, water solubility, and stability against aggregation, amide-triazole groups to enhance DNA binding affinity, and an oligoamine unit to facilitate DNA encapsulation, phosphate neutralization, and interactions with cell surfaces. A 2,3,4,2', 3', 4'-hexa-O-acetyl-6,6'-diazido-6,6'-dideoxy-(D)-trehalose (4) monomer was polymerized via copper(I)-catalyzed azide-alkyne cycloaddition with a series of dialkyne-amide comonomers that contain either one, two, or three Boc-protected secondary amines (7a, 7b, or 7c, respectively). After deprotection, three water-soluble polycations (9a, 9b, or 9c) were obtained with similar degrees of polymerization (n = 56-61) to elucidate the role of amine number on nucleic acid binding, complex formation, stability, and cellular delivery. Gel electrophoresis and ethidium bromide experiments showed that 9a-9c associated with plasmid DNA (pDNA) and formed complexes (polyplexes) at N/P ratios dependent on the amine number. TEM experiments revealed that 9a-9c polyplexes were small (50-120 nm) and had morphologies (spherical and rodlike) associated with the polymer chain stiffness. Dynamic light scattering studies in the presence of media containing serum demonstrated that 9c polyplexes had a low degree of flocculation, whereas 9a and 9b polyplexesd aggregate rapidly. Further biological studies revealed that these structures were biocompatible and deliver pDNA into HeLa cells. Particularly, 9c polyplexes promoted high delivery efficacy and gene expression profiles in the presence of serum.
    DOI:
    10.1021/ja0585580
点击查看最新优质反应信息

文献信息

  • A Facile Synthesis of Selectively Protected Linear Oligoamines
    作者:Simona Koščová、Miloš Buděšínský、Jana Hodačová
    DOI:10.1135/cccc20030744
    日期:——

    A convenient multi-gram preparative method for the synthesis of linear oligoamines having the terminal primary amino groups unprotected and the central secondary amino functions protected with tert-butoxycarbonyl groups is presented. At the same time, simple one-pot preparation of the α,ω-bis(trifluoroacetamide) intermediates 2 has been developed. NMR spectra of the novel selectively protected oligoamines are also discussed.

    一种方便的多克隆制备方法用于合成具有未保护的末端初级氨基团和中心次级氨基功能受到tert-丁氧羰基团保护的线性寡胺。同时,还开发了α,ω-双(三氟乙酰胺)中间体2的简单一锅制备方法。还讨论了新型选择性保护寡胺的NMR光谱。
  • Polyethylenimine analogs for improved gene delivery: effect of the type of amino groups
    作者:Miao-Miao Xun、Ju-Hui Zhang、Yan-Hong Liu、Ji Zhang、Ya-Ping Xiao、Qian Guo、Shuo Li、Xiao-Qi Yu
    DOI:10.1039/c5ra23715g
    日期:——

    The 1°, 2° and 3° amine composition of PEI analogs could be easily adjusted by special synthetic method, and their effects on the gene transfection were studied.

    PEI类似物的1°、2°和3°胺组成可以通过特殊的合成方法轻松调整,并研究它们对基因转染的影响。
  • Developing Bivalent Ligands to Target CUG Triplet Repeats, the Causative Agent of Myotonic Dystrophy Type 1
    作者:Amin Haghighat Jahromi、Yuan Fu、Kali A. Miller、Lien Nguyen、Long M. Luu、Anne M. Baranger、Steven C. Zimmerman
    DOI:10.1021/jm400794z
    日期:2013.12.12
    expanded CUG repeat transcript (CUGexp) is the causative agent of myotonic dystrophy type 1 (DM1) by sequestering muscleblind-like 1 protein (MBNL1), a regulator of alternative splicing. On the basis of a ligand (1) that was previously reported to be active in an in vitro assay, we present the synthesis of a small library containing 10 dimeric ligands (4–13) that differ in length, composition, and attachment
    扩展的 CUG 重复转录本 (CUG exp ) 是通过隔离肌盲样 1 蛋白 (MBNL1) 导致 1 型强直性肌营养不良 (DM1) 的病原体,MBNL1 是可变剪接的调节因子。基于先前报道在体外测定中具有活性的配体 ( 1 ),我们提出了一个包含 10个二聚配体 ( 4-13 )的小文库的合成,这些配体的长度、组成和附着点不同链接链。与寡醚接头相比,寡氨基接头对 CUG RNA 的亲和力更大,并且更有效。最有效的体外配体(9) 被证明是水溶性的并且具有细胞和细胞核渗透性,在 DM1 细胞模型中显示 MBNL1 核糖核病灶几乎完全分散。使用延时共聚焦荧光显微镜观察到9的生物活性的直接证据是其在单个活 DM1 模型细胞中分散核糖核病灶的能力。
  • Efficient Routes for the Synthesis of 1,4,7,10,13-Pentaazacyclohexadecane-14,16-dione
    作者:Bernhard Spingler、Chiara Da Pieve、Alfredo Medina-Molner
    DOI:10.1055/s-2007-965924
    日期:2007.3
    The synthetic access to 1,4,7,10,13-pentaazacyclohexadecane-14,16-dione was significantly improved from an overall yield of 1% to 33%. The procedure involved the use of COCF 3 or DDE as highly selective protecting groups for primary amines and of Boc to protect the secondary amine functions. The reaction of a tris-Boc protected tetraethylenepentamine with malonic acid gave the macrocycle in a 44% yield
    1,4,7,10,13-五氮杂环十六烷-14,16-二酮的合成获得率从1%的总收率显着提高到33%。该程序涉及使用 COCF 3 或 DDE 作为伯胺的高选择性保护基团和 Boc 以保护仲胺官能团。tris-Boc保护的四亚乙基五胺与丙二酸的反应产生44%产率的大环,然而与丙二酰氯的相同反应仅产生3.6%的所需产物。Boc 去保护和去除三氟乙酸盐得到最终产物 1,4,7,10,13-五氮杂环十六烷-14,16-二酮,总产率为 33%。
  • A Bioreducible Polymer for Efficient Delivery of Fas-Silencing siRNA into Stem Cell Spheroids and Enhanced Therapeutic Angiogenesis
    作者:Min Suk Shim、Suk Ho Bhang、Kyunghwan Yoon、Kyunghee Choi、Younan Xia
    DOI:10.1002/anie.201206595
    日期:2012.11.19
    Larger is better: Fas‐silencing siRNA can be delivered into the cytoplasm of human mesenchymal stem cells (hMSCs) by a bioreducible polymer (see picture). The enhanced anti‐apoptotic activity of the Fas‐silenced hMSCs means that they can be readily formulated as enlarged spheroids to significantly enhance angiogenic efficacy as compared to their smaller counterparts.
    越大越好:Fas 沉默 siRNA 可以通过生物可还原聚合物传递到人类间充质干细胞 (hMSC) 的细胞质中(见图)。Fas 沉默的 hMSC 增强的抗凋亡活性意味着它们可以很容易地配制成增大的球体,与较小的对应物相比,显着增强血管生成功效。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物